• Utopia Therapeutics raised $1.5 million in seed funding from Whale Tank to advance its lead candidate, UT009.
  • UT009 is a novel immunotherapeutic vaccine targeting obesity by modulating the immune system to reduce fat accumulation.

Hyderabad-based biotech startup Utopia Therapeutics has raised $1.5 million in seed funding from Whale Tank, an early-stage venture firm known for backing breakthrough life science innovations.

The startup, founded by scientists, is focused on developing next-generation immunotherapeutic vaccines for chronic metabolic diseases, with a particular focus on obesity.

The freshly raised capital will be used to accelerate the preclinical development of UT009, the company’s lead vaccine candidate.

UT009 is designed to modulate the immune system by targeting lipid-associated antigens, thereby reducing fat accumulation and improving metabolic health.

The funding will also help the company move UT009 through regulatory toxicology studies, IND-enabling milestones, and Phase I human clinical trials.

A Paradigm Shift in Obesity Treatment

Founders Dr. Uday Saxena and Dr. Gopi Kadiyala highlighted the significance of the partnership:

“We are thrilled to have Whale Tank as a strategic partner in our journey to redefine obesity treatment. Obesity is a global epidemic with limited long-term therapeutic options.
UT009 represents a paradigm shift by differentiating it from current obesity drugs by address the root causes of weight gain. This investment enables us to move swiftly toward clinical translation.”

The investment also marks another success story for India’s deep-tech ecosystem. Dr. Jitendra Kumar, Managing Director at BIRAC, emphasised the broader impact:

“A vaccine for metabolic disorders and a regenerative product pipeline coming out of India and entering global markets demonstrates the scientific depth and entrepreneurial maturity that BIRAC has consistently fostered... This is a great enabling system.”

Whale Tank’s Managing Partner, Dr. Markandeya Gorantla, expressed confidence in Utopia’s approach:

“Utopia’s approach is bold, scientifically rigorous, and offers enormous potential to disrupt the obesity market.
We are excited to support their mission of bringing Immunotherapeutics to the forefront of chronic disease management.”

Edited by Annette George